Skip to main content

Table 5 Demographic and clinical characteristics of cannabis users and non-users on MMT

From: Association between cannabis use and methadone maintenance treatment outcomes: an investigation into sex differences

Variable

Cannabis non-users (n = 372)

Cannabis users (n = 405)

p value

Age in years (SD)

39.78 (11.05)

36.46 (10.94)

<0.001

Sex (% female)

205 (55.1%)

158 (39.0%)

<0.001

Ethnicity (% Caucasian)

306 (83.4%)

329 (81.8%)

0.634

Marital status

 Never married (%)

150 (40.3%)

211 (52.1%)

0.004

 Married/common law/living with partner (%)

126 (33.9%)

112 (27.7%)

 

 Widowed/separated/divorced (%)

96 (25.8%)

82 (20.2%)

 

Education

 Less than grade 9 (%)

67 (18.2%)

89 (22.0%)

0.087

 Grade 9–12 (%)

190 (51.6%)

220 (54.5%)

 

 Trade school, college, university (%)

111 (30.2%)

95 (23.5%)

 

Employment (% currently working)

132 (35.5%)

141 (34.8%)

0.880

Smoking status (% current smoker)

301 (80.9%)

355 (87.7%)

0.010

Age of onset of opioid use in years (SD)

26.12 (9.08)

23.86 (7.86)

<0.001

Methadone dose in mg per day (SD)

78.77 (46.54)

72.36 (45.02)

0.053

Current treatment duration in years (SD)

4.26 (4.35)

3.85 (3.91)

0.164

Physical functioning (SD)

15.06 (7.92)

16.02 (7.38)

0.085

Psychological functioning (SD)

12.90 (9.57)

14.27 (8.76)

0.040

  1. Maximum score for the MAP physical and psychological functioning is 40, with higher scores indicating worse functioning
  2. SD standard deviation